|
|
|
|
These prospective multicenter findings demonstrate that patients undergoing intracardiac surgery combined with coronary revascularization are at formidable risk, in that 1 in 6 will develop cerebral complications that are frequently costly and devastating. Thus, new strategies for perioperative management - including technical and pharmacological interventions - are now mandated for this subgroup of cardiac surgery patients. |
|